Keyword: Johnson & Johnson
News
27.05.2016
- Janssen-Cilag, a subsidiary of US healthcare giant Johnson & Johnson, has been granted conditional approval in Europe for Darzalex (daratumumab) to treat patients with relapsed and...
News
04.05.2016
- US healthcare giant Johnson & Johnson plans to appeal a US jury’s award of $55 million in damages to Gloria Ristesund, who blamed her ovarian cancer – now in remission – on the...
News
12.04.2016
- The Roundtable on Sustainable Palm Oil (RSPO) has suspended the certification of IOI, a Malaysian palm oil company that supplies palm oil to more than 300 companies worldwide. The...
Strategy & Management
04.04.2016
- Alliances between big pharma and scientists, hospitals and biotech firms are common practice in the health-care business. About half of today’s top-selling drugs are the result of...
News
26.02.2016
- A jury hearing a claim in a Missouri state circuit court against US healthcare giant Johnson & Johnson (J&J) has found the company liable for fraud, negligence and conspiracy in...
News
05.02.2016
- Major drugs companies Johnson & Johnson (J&J) and GlaxoSmithKline (GSK) have become partners in a €210 million life sciences venture capital fund. Both groups will each contribute...
Chemistry & Life Sciences
03.02.2016
- A key upcoming industry event is DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT). DCAT Week brings together pharmaceutical and...
News
02.02.2016
- Rheumatoid arthritis sufferers in England will soon be able to benefit from a cheaper generic version of US pharmaceutical producer Merck’s and the world’s best-selling medicines...
